Genhui Chen
President bij Beijing Wenfeng Medical Technology Ltd.
Profiel
Genhui Chen is currently the President of Beijing Wenfeng Medical Technology Ltd.
He previously served as the President & Chief Executive Officer of Welichem Biotech, Inc. from 1995 to 2009.
From 2013 to 2016, he was an Independent Director at Lianluo Smart Ltd.
Chen received a graduate degree from Simon Fraser University in 1988 and a doctorate degree from the same institution in 1991.
Actieve functies van Genhui Chen
Bedrijven | Functie | Begin |
---|---|---|
Beijing Wenfeng Medical Technology Ltd. | President | - |
Eerdere bekende functies van Genhui Chen
Bedrijven | Functie | Einde |
---|---|---|
NEWEGG COMMERCE, INC. | Directeur/Bestuurslid | 25-10-2016 |
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | President | 17-11-2009 |
Opleiding van Genhui Chen
Simon Fraser University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Welichem Biotech, Inc.
Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada. | Health Technology |
Lianluo Smart Ltd.
Lianluo Smart Ltd. Medical SpecialtiesHealth Technology Lianluo Smart Ltd. engages in the development and marketing of medical wearable devices, smart devices and ecosystem platform. The medical wearable sector focuses on wearable sleep respiratory devices, focusing primarily on sleep respiratory solutions to obstructive sleep apnea syndrome. The smart devices sector is specialized in operating easy-use smart devices for sports, social contact, entertainment, remote-control and family health management, which can connect things and humans in an intelligent way. The smart ecosystem platform sector, intends to build an ecosystem to facilitate interconnection among smart products and between smart products and users. The company was founded by Ping Chen on July 22, 2003 and is headquartered in Beijing, China. | Health Technology |
Beijing Wenfeng Medical Technology Ltd. |